相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations
Carole Trzaska et al.
NATURE COMMUNICATIONS (2020)
Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency
Jonathan Frew et al.
MOLECULAR NEURODEGENERATION (2020)
Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides
Tobias Merkle et al.
NATURE BIOTECHNOLOGY (2019)
In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
Dhruva Katrekar et al.
NATURE METHODS (2019)
Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study
Marco Tutone et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Engineered transfer RNAs for suppression of premature termination codons
John D. Lueck et al.
NATURE COMMUNICATIONS (2019)
CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
Choongil Lee et al.
MOLECULAR THERAPY (2019)
Quality and quantity control of gene expression by nonsense-mediated mRNA decay
Tatsuaki Kurosaki et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations
Lulu Huang et al.
NUCLEIC ACID THERAPEUTICS (2019)
AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290 c.4723A > T Mutation. Fact or Fiction?
Iris Barny et al.
GENES (2019)
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
Ambra Campofelice et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
Liang Qu et al.
NATURE BIOTECHNOLOGY (2019)
Base-pairing interactions between substrate RNA and H/ACA guide RNA modulate the kinetics of pseudouridylation, but not the affinity of substrate binding by H/ACA small nucleolar ribonucleoproteins
Erin K. Kelly et al.
RNA (2019)
Targeted exon skipping rescues ciliary protein composition defects in Joubert syndrome patient fibroblasts
Elisa Molinari et al.
SCIENTIFIC REPORTS (2019)
Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations
Ananya Samanta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR
Melissa M. Keenan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers
Andi Leubitz et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
A Bump-Hole Approach for Directed RNA Editing
Leanna R. Monteleone et al.
CELL CHEMICAL BIOLOGY (2019)
Aminoglycoside-mediated promotion of translation readthrough occurs through a non-stochastic mechanism that competes with translation termination
H. M. Chowdhury et al.
HUMAN MOLECULAR GENETICS (2018)
Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme
Isabel C. Vallecillo-Viejo et al.
RNA BIOLOGY (2018)
RNA editing in nascent RNA affects pre-mRNA splicing
Yun-Hua Esther Hsiao et al.
GENOME RESEARCH (2018)
Translational research to enable personalized treatment of cystic fibrosis
Marne C. Hagemeijer et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Guide-substrate base-pairing requirement for box H/ACA RNA-guided RNA pseudouridylation
Meemanage D. De Zoysa et al.
RNA (2018)
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs
Ivana Pibiri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting mutant p53 for efficient cancer therapy
Vladimir J. N. Bykov et al.
NATURE REVIEWS CANCER (2018)
Antisense suppression of the nonsense mediated decay factor Upf3b as a potential treatment for diseases caused by nonsense mutations
Lulu Huang et al.
GENOME BIOLOGY (2018)
Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy
Jacqueline Wettengel et al.
NUCLEIC ACIDS RESEARCH (2017)
RNA modification in Cajal bodies
U. Thomas Meier
RNA BIOLOGY (2017)
Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases
Hana Benhabiles et al.
PLOS ONE (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome
Christine Neuhaus et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay
Tomoki T. Nomakuchi et al.
NATURE BIOTECHNOLOGY (2016)
Human nonsense-mediated mRNA decay factor UPF2 interacts directly with eRF3 and the SURF complex
Andres Lopez-Perrote et al.
NUCLEIC ACIDS RESEARCH (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ribosome profiling reveals the what, when, where and how of protein synthesis
Gloria A. Brar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
A network of SMG-8, SMG-9 and SMG-1 C-terminal insertion domain regulates UPF1 substrate recruitment and phosphorylation
Aurelien Deniaud et al.
NUCLEIC ACIDS RESEARCH (2015)
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
Xiaojiao Xue et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
A post-translational regulatory switch on UPF1 controls targeted mRNA degradation
Tatsuaki Kurosaki et al.
GENES & DEVELOPMENT (2014)
Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies
Pascale Fanen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Therapeutic suppression of premature termination codons: Mechanisms and clinical considerations (Review)
John Karijolich et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
Laura Lentini et al.
MOLECULAR PHARMACEUTICS (2014)
Cryoelectron Microscopic Structures of Eukaryotic Translation Termination Complexes Containing eRF1-eRF3 or eRF1-ABCE1
Anne Preis et al.
CELL REPORTS (2014)
Ataluren as an Agent for Therapeutic Nonsense Suppression
Stuart W. Peltz et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
The SMG5-SMG7 heterodimer directly recruits the CCR4-NOT deadenylase complex to mRNAs containing nonsense codons via interaction with POP2
Belinda Loh et al.
GENES & DEVELOPMENT (2013)
Temporal and spatial characterization of nonsense-mediated mRNA decay
Tatjana Trcek et al.
GENES & DEVELOPMENT (2013)
Unusual base pairing during the decoding of a stop codon by the ribosome
Israel S. Fernandez et al.
NATURE (2013)
Translation-dependent displacement of UPF1 from coding sequences causes its enrichment in 3 ' UTRs
David Zuend et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing
Maria Fernanda Montiel-Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cryo-EM structure of the mammalian eukaryotic release factor eRF1-eRF3-associated termination complex
Derek Taylor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular Mechanisms for the RNA-Dependent ATPase Activity of Upf1 and Its Regulation by Upf2
Sutapa Chakrabarti et al.
MOLECULAR CELL (2011)
Converting nonsense codons into sense codons by targeted pseudouridylation
John Karijolich et al.
NATURE (2011)
Upf1 Senses 3′UTR Length to Potentiate mRNA Decay
J. Robert Hogg et al.
CELL (2010)
SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay
Akio Yamashita et al.
GENES & DEVELOPMENT (2009)
Structural insights into eRF3 and stop codon recognition by eRF1
Zhihong Cheng et al.
GENES & DEVELOPMENT (2009)
SMG6 promotes endonucleolytic cleavage of nonsense mRNA in human cells
Andrea B. Eberle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
A meta-analysis of nonsense mutations causing human genetic disease
Matthew Mort et al.
HUMAN MUTATION (2008)
Specificity of ADAR-mediated RNA editing in newly identified targets
Eva M. Riedmann et al.
RNA (2008)
The exosome: a multipurpose RNA-decay machine
Manfred Schmid et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
NMD factors UPF2 and UPF3 bridge UPF1 to the exon junction complex and stimulate its RNA helicase activity
Hala Chamieh et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
RNA quality control in eukaryotes
Meenakshi K. Doma et al.
CELL (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
The role of N-terminal domain of translational release factor eRF3 for the control of functionality and stability in S-cerevisiae
Hiroyuki Kodama et al.
GENES TO CELLS (2007)
The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
Marcelo H. Viegas et al.
NUCLEIC ACIDS RESEARCH (2007)
Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay
I Kashima et al.
GENES & DEVELOPMENT (2006)
Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core
TO Tange et al.
RNA (2005)
Crystal structure and functional analysis of the eukaryotic class II release factor eRF3 from S. pombe
CG Kong et al.
MOLECULAR CELL (2004)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
Dynamic association of RNA-editing enzymes with the nucleolus
JMP Desterro et al.
JOURNAL OF CELL SCIENCE (2003)
Making sense of mimic in translation termination
Y Nakamura et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in cap/poly(A)-dependent translation
N Uchida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2
GC Jayan et al.
JOURNAL OF VIROLOGY (2002)
When the message goes awry: Disease-producing mutations that influence mRNA content and performance
JT Mendell et al.
CELL (2001)
Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay
A Yamashita et al.
GENES & DEVELOPMENT (2001)
Mammalian heat shock p70 and histone H4 transcripts, which derive from naturally intronless genes, are immune to nonsense-mediated decay
LE Maquat et al.
RNA (2001)
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions
H Le Hir et al.
EMBO JOURNAL (2000)
Characterization of the biochemical properties of the human Upf1 gene product that is involved in nonsense-mediated mRNA decay
A Bhattacharya et al.
RNA (2000)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion
QL Lu et al.
JOURNAL OF CELL BIOLOGY (2000)
The crystal structure of human eukaryotic release factor eRF1 - Mechanism of stop codon recognition and peptidyl-tRNA hydrolysis
HW Song et al.
CELL (2000)
Translation termination in eukaryotes: Polypeptide release factor eRF1 is composed of functionally and structurally distinct domains
LY Frolova et al.
RNA (2000)
分享论文
